Guideline for parenteral nutrition of the DGEM. Part 19: Non-surgical oncology;19 Nichtchirurgische onkologie

Aktuelle Ernahrungsmedizin

Volumn 32, Issue SUPPL. 1, 2007, Pages

  Arends, J ^a   Zurcher C ^a   Dossett, A ^a   Fietkau, R ^a   Hug, M J ^a   Schmid, I ^a   Shang, E ^a   Zander, A R ^a  

^a NONE

Author keywords

Chemotherapy; Radiotherapy; Stem cell transplantation; Tumour

Indexed keywords

CANCER PATIENT; CANCER THERAPY; ENTERIC FEEDING; GERMANY; HUMAN; INCIDENCE; MEDICAL SOCIETY; MORBIDITY; MORTALITY; PARENTERAL NUTRITION; PATIENT MONITORING; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; TREATMENT INDICATION;

EID: 34447563814     PISSN: 03410501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (171)

1. Tubiana M, Attié E, Flamant R, Gérard-Marchant R, Hayat M. Prognostic factors in 454 cases of Hodgkin's Disease. Cancer Res 1971; 31: 1801-1810
2. Swenerton KD, Legha SS, Smith T et al. Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 1979; 39: 1552-1562
3. DeWys WD, Begg C, Lavin PT et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980; 69: 491-497
4. Eys J van. Effect of nutritional status on response to therapy. Cancer Res 1982; 42: 747-753
5. Pedersen H, Hansen HS, Cederqvist C, Lober J. The prognostic significance of weight loss and its integration in stage-grouping of oesophageal cancer. Acta Chir Scand 1982; 148: 363-366
6. Burning PF, Egger RJ, Gooskens AC et al. Dietary intake, nutritional status and well-being of cancer patients: a prospective study. Eur J Cancer 1985; 21: 1449-1459
7. Padilla GV. Psychological aspects of nutrition and cancer. Surg Clin North Am 1986; 66: 1121-1135
8. Andreyev HJN, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 1998; 34: 503-509
9. Argiris A, Li Y, Forastiere A. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck. Cancer 2004; 101: 2222-2229
10. Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Cancer: disease and nutrition are key determinants of patients' quality of life. Supp Care Cancer 2004; 12: 246-252
11. Ross PJ, Ashley S, Norton A et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? British Journal of Cancer 2004; 90: 1905-1911
12. Warren S. The immediate causes of death in cancer. Am J Med Sci 1932; 184: 610-615
13. Aslani A, Smith RC, Allen BJ, Paviakis N, Levi JA. The predictive value of body protein for chemotherapy-induced toxicity. Cancer 2000; 88: 796-803
14. Donaldson SS, Wesley MN. A study of the nutritional status of pediatric cancer patients. Am J Dis Child 1981; 135: 1107-1112
15. Rickard KA, Detamore CM, Coates TD et al. Effect of nutrition staging on treatment delays and outcome in Stage IV neuroblastoma. Cancer 1983; 52: 587-598
16. Lobato-Mendizabal E, Ruiz-Arguelles GJ, Matin-Lopez A. Leukaemia and nutrition. I: Malnutrition is an adverse prognostic factor in the outcome of treatment of patients with standard-risk acute lymphoblastic leukaemia. Leuk Res 1989; 13: 899-906
17. Viana MB, Murao M, Ramos G et al. Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. Arch Dis Child 1994; 71: 304-310
18. Mejia-Arangure JM, Fajardo-Gutienez A, Reyes-Ruiz NI et al. Malnutrition in childhood lymphoblastic leukemia: a predictor of early mortality during the induction-to-remission phase of the treatment. Arch Med Res 1999; 30: 150-153
19. Weir J, Reilly JJ, McColl JH, Gibson BE. No evidence for an effect of nutritional status at diagnosis on prognosis in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 1998; 20: 534-538
20. Pedrosa F, Bonilla M, Liu A et al. Effect of malnutrition at the time of diagnosis on the survival of children treated for cancer in El Salvador and Northern Brazil. J Pediatr Hematol Oncol 2000; 22: 502-505
21. Wessels GHP. Nutrition, morbidity and survival in South African children with Wilms tumor. J Pediatr Hematol Oncol 1999; 16: 321-327
22. Yaris N, Akyuz C, Coskun T, Kutluk T, Buyukpamukcu M. Nutritional status of children with cancer and its effects on survival. Turk J Pediatr 2002; 44: 35-39
23. Rickard KA, Grosfeld JL, Kirksey A, Ballantine TV, Baehner RL. Reversal of protein-energy malnutrition in children during treatment of advanced neoplastic disease. Ann Surg 1979; 190: 771-781
24. Picton SV. Aspects of altered metabolism in children with cancer. Int J Cancer Suppl 1998; 11: 62-64
25. Halton JM, Scissons-Fisher CC. Impact of nutritional status on morbidity and dose intensity of chemotherapy during consolidation therapy in children with acute lymphoblastic leukaemia. J Pediatr Hematol Oncol 1999; 21: 317
26. Hughes WT, Price RA, Sisko F et al. Protein-calorie malnutrition. A host determinant for Pneumocystis carinii infection. AmJ Dis Child 1974; 128: 44-52
27. Taj MM, Pearson AD, Mumford DB, Price L. Effect of nutritional status on the incidence of infection in childhood cancer. Pediatr Hematol Oncol 1993; 10: 283-287
28. Obama M, Cangir A, Eys J van. Nutritional status and anthracycline cardiotoxicity in children. South Med J 1983; 76: 577-578
29. Bosaeus I, Daneryd P, Svanberg E, Lundholm K. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 2001; 93: 380-383
30. Knox IS, Crosby LO, Fewer ID, Buzby GP, Miller CL, Mullen JL. Energy expenditure in malnourished cancer patients. Ann Surg 1983; 197: 152-161
31. Dempsey DT, Feurer ID, Knox IS, Crosby LO, Buzby GP, Mullen JL. Energy expenditure in malnourished gastrointestinal cancer patients. Cancer 1984; 53: 1265-1273
32. Dempsey DT, Knox LS, Mullen JL, Miller CL, Feurer ID, Buzby GP. Energy expenditure in malnourished patients with colorectal cancer. Arch Surg 1986; 121: 789-795
33. Hansell DT, Davies JW, Burns HJ. Effects of hepatic metastases on resting energy expenditure in patients with colorectal cancer. Br J Surg 1986; 73: 659-662
34. Fredrix EW, Soeters PB, Wouters EF, Deerenberg IM, Meyenfeldt MF von, Saris WH. Effect of different tumor types on resting energy expenditure. Cancer Res 1991; 51: 6138-6141
35. Gibney E, Elia M, Jebb SA, Murgatroyd P, Jennings G. Total energy expenditure in patients with small-cell lung cancer: results of a validated study using the bicarbonate-urea method. Metabolism 1997; 46: 1412-1417
36. Moses AW, Slater C, Preston T, Barber MD, Fearon KC. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 2004; 90: 996-1002
37. Kien CL, Camitta BM. Close association of accelerated rates of whole body protein turnover (synthesis and breakdown) and energy expenditure in children with newly diagnosed acute lymphocytic leukemia. JPENJ Parenter Enteral Nutr 1987; 11: 129-134
38. Stallings VA, Vaisman N, Chan HS, Weitzman SS, Hahn E, Pencharz PB. Energy metabolism in children with newly diagnosed acute lymphoblastic leukemia. Pediatr Res 1989; 26: 154-157
39. Bond SA, Han AM, Wootton SA, Kohler JA. Energy intake and basal metabolic rate during maintenance chemotherapy. Arch Dis Child 1992; 67: 229-232
40. Vaisman N, Stallings VA, Chan H, Weitzman SS, Clarke R, Pencharz PB. Effect of chemotherapy on the energy and protein metabolism of children near the end of treatment for acute lymphoblastic leukemia. Am J Clin Nutr 1993; 57: 679-684
41. Broeder E den, Oeseburg B, Lippens RJ et al. Basal metabolic rate in children with a solid tumour. Eur J Clin Nutr 2001; 55: 673-681
42. Moldawer LL, Copeland EM. Proinflammatory cytokines, nutritional support, and the cachexia syndrom. Cancer 1997; 79: 1828-1839
43. Blaauw I de, Deutz NEP, Meyenfeldt MF von. Metabolic changes in cancer cachexia - first of two parts. Clin Nutr 1997; 16: 169-176
44. Blaauw I de, Deutz NEP, Meyenfeldt MF von. Metabolic changes of cancer cachexia - second of two parts. Clin Nutr 1997; 16: 223-228
45. Inui A. Cancer anorexia-cachexia syndrome: Are neuropeptides the key? Cancer Res 1999; 59: 4493-4501
46. Ramos EJ, Suzuki S, Marks D, Inui A, Asakawa A, Meguid MM. Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care 2004; 7: 427-434
47. Fearon KCH, Barber MD, Falconer JS, McMillan DC, Ross JA, Preston T. Pancreatic cancer as a model: Inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg 1999; 23: 584-588
48. Fordy C, Glover C, Henderson DC, Summerbell C, Wharton R, Allen-Mersh TG. Contribution of diet, tumour volume and patient-related factors to weight loss in patients with colorectal liver metastases. Br J Surg 1999; 86: 639-644
49. Simons JPFHA, Schols AM, Buurman WA, Wouters EF. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci 1999; 97: 215-223
50. Meyenfeldt MF von. Nutritional support during treatment of biliopancreatic malignancy. Ann Oncol 1999; 10: 273-277
51. Espat NJ, Moldawer LL, Copeland EM. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients. J Surg Oncol 1995; 58: 77-82
52. Martin F, Santolaria F, Batista N et al. Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine 1999; 11: 80-86
53. O'Gorman P, McMillan DC, McArdle CS. Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer 2000; 37: 36-40
54. Lundholm K, Holm G, Schersten T. Insulin resistance in patients with cancer. Cancer Res 1978; 38: 4665-4670
55. Starnes HF, Warren RS, Brennan MF. Protein synthesis in hepatocytes isolated from patients with gastrointestinal malignancy. J Clin Invest 2002; 80: 1384-1390
56. Shaw JHF, Wolfe RR. Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. Ann Surg 1997; 205: 368-376
57. Zuijdgeest-van Leeuwen SD, Berg JWO van den, Wattimena JLD et al. Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects. Metabolism 2000; 49: 931-936
58. Körber J, Pricelius S, Heidrich M, Müller MJ. Increased lipid utilization in weight losing and weight stable cancer patients with normal body weight. Eur J Clin Nutr 1999; 53: 740-745
59. Barber MD, McMillan DC, Preston T, Ross JA, Fearon KCH. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supllement. Clin Sci 2000; 98: 389-399
60. Legaspi A, Jeevanandam M, Starnes HF Jr, Brennan MF. Whole body lipid and energy metabolism in the cancer patient. Metabolism 1987; 36: 958-963
61. Jeevanandam M, Horowitz GD, Lowry SF, Brennan MF. Cancer cachexia and protein metabolism. Lancet 1984; 1: 1424-1426
62. Williams A, Sun X, Fischer JF, Hasselgren PO. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery 1999; 126: 744-750
63. Bossola M, Muscaritoli M, Costelli P et al. Increased muscle ubiquitin mRNA levels in gastric cancer patients. Am J Physiol Regulatory Integrative Comp Phsyiol 2001; 280: R1518-R1523
64. Tisdale MJ. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. The Journal of Supportive Oncology 2005; 3: 209-217
65. Tisdale MJ. Protein loss in cancer cachexia. Science 2000; 289: 2293
66. Cabal-Manzano R, Bhargava P, Torres-Duarte A, Marshall J, Bhargava P, Wainer IW. Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss. British Journal of Cancer 2001; 84: 1599-1601
67. Scolapio JS, Ukleja A, Burnes JU, Kelly DG. Outcome of patients with radiation enteritis treated with home parenteral nutrition. American Journal of Gastroenterology 2002; 97: 662-666
68. Hyltander A, Drott C, Unsgaard B et al. The effect on body composition and exercise performance of home parenteral nutrition when given as adjunct to chemotherapy of testicular carcinoma. Eur J Clin Invest 1991; 21: 413-420
69. Cozzaglio L, Balzola F, Cosentino F et al. Outcome of cancer patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 1997; 21: 339-342
70. Meuret G, Springer J. Parenterale Heimernährung bei fortgeschrittenen Tumorkrankheiten. Akt Ernährungsmed 1999; 24: 270-276
71. Bozzetti F, Cozzaglio L, Biganzoli E et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr 2002; 21: 281-288
72. Fearon KCH, Meyenfeldt MF von, Moses AG et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 2003; 52: 1479-1486
73. Howard L. Home parenteral nutrition in patients with a cancer diagnosis. JPEN J Parenter Enteral Nutr 1992; 16: 93S-99S
74. Pironi L, Ruggeri E, Tanneberger S, Giordani S, Pannuti F, Miglioli M. Home artificial nutrition in advanced cancer. J R Soc Med 1997; 90: 597-603
75. Scolapio JS, Fleming CR, Kelly DG. Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic. May Clin Proc 1999; 74: 217-222
76. Duerksen DR, Ting E, Thomson P et al. Is there a role for TPN in terminally ill patients with bowel obstruction? Nutrition 2004; 20: 760-763
77. Moreno Vilares JM, Gomis Munoz P, Valero Zanuy MA, Leon Sanz M. Home parenteral nutrition in patients with advanced cancer: experience of a single centre over ten years. Nutr Hosp 2004; 19: 253-258
78. Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience. Cancer 2005; 103: 863-868
79. Orrevall Y, Tishelman C, Herrington MK, Permert J. The path from oral nutrition to home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clin Nutr 2004; 23: 1280-1287
80. Braunschweig C, Liang HF, Sheean P. Indications for administration of parenteral nutrition in adults. Nutr Clin Pract 2004; 19: 255-262
81. Klein S, Koretz RL. Nutrition support in patients with cancer: What do the data really show? Nutr Clin Pract 1994; 9: 91-100
82. Ollenschläger G, Konkol K, Mödder B. Indications for and results of nutritional therapy in cancer patients. Rec Res Cancer Res 1988; 108: 172-184
83. Sax HC, Souba WW. Enteral and parenteral feedings. Guidelines and recommendations. Med Clin North Am 1993; 77: 863-880
84. Hackl JM, Balogh D. Indikation zur künstlichen Ernährung - was ist gesichert? Akt Ernährungsmed 1997; 22: 146-153
85. Koretz RL, Lipman TO, Klein S American Gastroenterological Association. AGA technical review on parenteral nutrition. Gastroenterology 2001; 121: 970-1001
86. ASPEN Board of Directors and the Clinical Guidelines Task Force. Indications for specialized nutrition support. JPEN J Parenter Enteral Nutr 2002; 26: 18SA-20SA
87. Bozzetti F. Home total parenteral nutrition in incurable cancer patients: a therapy, a basic humane care or something in between? Clin Nutr 2003; 22: 109-111
88. Druml W, Jadrna K, Roth E. Empfehlungen für die enterale und parenteral Ernährungstherapie des Erwachsenen. Wien: Arbeitsgemeinschaft für klinische Ernährung (AKE), 2004
89. Brennan MF, Ekman L. Metabolic consequences of nutritional support of the cancer patient. Cancer 1984; 54: 2627-2634
90. Bozzetti F, Gavazzi C, Ferrari P, Dworzak F. Effect of total parenteral nutrition on the protein kinetics of patients with cancer cachexia. Tumori 2000; 86: 408-411
91. Bozzetti F, Bozzetti V. Efficacy of enteral and parenteral nutrition in cancer patients. Nestle Nutr Workshop Ser Clin Perform Programme 2005; 10: 127-139
92. Baron PL, Lawrence W Jr, Chan WM, White FK, Banks WL Jr. Effects of parenteral nutrition on cell cycle kinetics of head and neck cancer. Arch Surg 1986; 121: 1282-1286
93. Heys SD, Park KG, McNurlan MA et al. Stimulation of protein synthesis in human tumours by parenteral nutrition: evidence for modulation of tumour growth. Br J Surg 1991; 78: 483-487
94. Cao WX, Xiao HB, Yin HR. Effects of preoperative parenteral nutritional support with chemotherapy on tumor cell kinetics in gastric cancer patients. Chung-Hua Chung Liu Tsa Chih [Chinese Journal of Oncology] 1994; 16: 137-140
95. McNurlan MA, Heys SD, Park KG et al. Tumour and host tissue responses to branched-chain amino acid supplementation of patients with cancer. Clin Sci (Lond) 1994; 86: 339-345
96. Bozzetti F, Gavazzi C, Cozzaglio L, Costa A, Spinelli P, Viola G. Total parenteral nutrition and tumor growth in malnourished patients with gastric cancer. Tumori 1999; 85: 163-166
97. Jin D, Phillips M, Byles JE. Effects of parenteral nutrition support and chemotherapy on the phasic composition of tumor cells in gastrointestinal cancer. JPEN J Parenter Enteral Nutr 1999; 23: 237-241
98. Donaldson SS, Wesley MN, Ghavimi F, Shils ME, Suskind RM, DeWys WD. A prospective randomized clinical trial of total parenteral nutrition in children with cancer. Med Pediatr Oncol 1982; 10: 129-139
99. Rickard KA, Loghmani ES, Grosfeld JL et al. Short- and long-term effectiveness of enteral and parenteral nutrition in reversing or preventing protein-energy malnutrition in advanced neuroblastoma. A prospective randomized study. Cancer 1985; 56: 2881-2897
100. Rickard KA, Godshall BJ, Loghmani ES et al. Integration of nutrition support into oncologic treatment protocols for high and low nutritional risk children with Wilms' tumor. A prospective randomized study. Cancer 1989; 64: 491-509
101. Eys J van, Copeland EM, Cangir A et al. A clinical trial of hyperalimentation in children with metastatic malignancies. Med Pediatr Oncol 1980; 8: 63-73
102. Ghavimi F, Shils ME, Scott BF, Brown M, Tamaroff M. Comparison of morbidity in children requiring abdominal radiation and chemotherapy, with and without total parenteral nutrition. J Pediatr 1982; 101: 530-537
103. Hays DM, Merritt RJ, White L, Ashley J, Siegel SE. Effect of total parenteral nutrition on marrow recovery during induction therapy for acute nonlymphocytic leukemia in childhood. Med Pediatr Oncol 1983; 11: 134-140
104. Shamberger RC, Pizzo PA, Goodgame JT Jr et al. The effect of total parenteral nutrition on chemotherapy-induced myelosuppression. A randomized study. Am J Med 1983; 74: 40-48
105. IUCC Workshop. Nutritional morbidity in children with cancer: Mechanisms, measures and management. Int J Cancer Suppl 1998; 78 (Suppl II): 1-92
106. Weisdorf SA, Lysne J, Wind D et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 1987; 43: 833-838
107. Christensen ML, Hancock ML, Gattuso J et al. Parenteral nutrition associated with increased infection rate in children with cancer. Cancer 1993; 72: 2732-2738
108. Bakish J, Hargrove D, Tariq N, Laperriere N, Rutka JT, Bouffet E. Evaluation of dietetic intervention in children with medulloblastoma or supratentorial primitive neuroectodermal tumors. Cancer 2003; 98: 1014-1020
109. Nitenberg G, Raynard B. Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 2000; 34: 137-168
110. Holm E, Hagmuller E, Staedt U et al. Substrate balances across colonic carcinomas in humans. Cancer Res 1995; 55: 1373-1378
111. Bozzetti F, Gavazzi C, Mariani L, Crippa F. Glucose-based total parenteral nutrition does not stimulate glucose uptake by humans tumours. Clin Nutr 2004; 23: 417-421
112. Ulrich H, Pastores SM, Katz DP, Kvetan V. Parenteral use of medium-chain triglycerides: a reappraisal. Nutrition 1996; 12: 231-238
113. Waitzberg DL, Lotierzo PH, Logullo AF, Torrinhas RS, Pereira CC, Meier R. Parenteral lipid emulsions and phagocytic systems. Br J Nutr 2002; 87, Suppl 1: S49-S57
114. Savarese DM, Savy G, Vahdat L, Wischmeyer PE, Corey B. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev 2003; 29: 501-513
115. Ziegler TR, Young IS, Benfell K et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 1992; 116: 821-828
116. Schloerb PR, Amare M. Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). JPEN J Parenter Enteral Nutr 1993; 17: 407-413
117. Schloerb PR, Skikne BS. Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study. JPEN J Parenter Enteral Nutr 1999; 23: 117-122
118. Ziegler TR, Bye RL, Persinger RL, Young IS, Antin JH, Wilmore DW. Effects of glutamine supplementation on circulating lymphocytes after bone marrow transplantation: a pilot study. Am J Med Sci 1998; 315: 4-10
119. Pytlik R, Benes P, Patorkova M et al. Standardized parenteral alanylglutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study. Bone Marrow Transplant 2002; 30: 953-961
120. Brown SA, Goringe A, Fegan C et al. Parenteral glutamine protects hepatic function during bone marrow transplantation. Bone Marrow Transplant 1998; 22: 281-284
121. Zaanen HCT van, Lelie H van der, Timmer JG, Fürst P, Sauerwein HP. Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity. Cancer 1994; 74: 2879-2884
122. Scheid C, Hermann K, Kremer G et al. Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia undergoing intensive chemotherapy. Nutrition 2004; 20: 249-254
123. ASPEN Board of Directors and the Clinical Guidelines Task Force. Specific guidelines for disease - adults: Cancer - hematopoetic cell transplantation. JPEN J Parenter Enteral Nutr 2002; 26: 83SA-85SA
124. Arfons LM, Lazarus HM. Total parenteral nutrition and hematopoietic stem cell transplantation: an expensive placebo? Bone Marrow Transplant 2005; 36: 281-288
125. Fietkau R. Principles of feeding cancer patients via enteral or parenteral nutrition during radiotherapy. Strahlenther Onkol 1998; 174, Suppl 3: 47-51
126. Body JJ. Metabolic sequelae of cancers (excluding bone marrow transplantation). Curr Opin Clin Nutr Metab Care 1999; 2: 339-344
127. Celaya PS, Valero Zanuy MA. Nutritional management of oncologic patients. Nutr Hosp 1999; 14, Suppl 2: 43S-52S
128. Schattner MA, Willis HJ, Raykher A et al. Long-term enteral nutrition facilitates optimization of body weight. JPEN J Parenter Enteral Nutr 2005; 29: 198-203
129. Miller DG, Ivey M, Young J. Home parenteral nutrition in treatment of severe radiation enteritis. Ann Intern Med 1979; 91: 858-860
130. Lavery IC, Steiger E, Fazio VW. Home parenteral nutrition in management of patients with severe radiation enteritis. Dis Colon Rectum 1980; 23: 91-93
131. Lentz SS, Schray MF, Wilson TO. Chylous ascites after whole-abdomen irradiation for gynecologic malignancy. Int J Rad Oncol Biol Phys 1990; 19: 435-438
132. Silvain C, Besson I, Ingrand P et al. Long-term outcome of severe radiation enteritis treated by total parenteral nutrition. Dig Dis Sci 1992; 37: 1065-1071
133. McGeer AJ, Detsky AS, O'Rourke K. Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis. Nutrition 1990; 6: 233-240
134. Cicco M De, Panarello G, Fantin D et al. Parenteral nutrition in cancer patients receiving chemotherapy: effects on toxicity and nutritional status. JPEN J Parenter Enteral Nutr 1993; 17: 513-518
135. ASPEN Board of Directors and the Clinical Guidelines Task Force. Specific guidelines for disease - adults: cancer. JPEN J Patenter Enteral Nutr 2002; 26: 82SA-83SA
136. Bozzetti F, Mariani L, Bertinet DB et al. Central venous catheter complications in 447 patients on home parenteral nutrition: an analysis of over 100 000 catheter days. Clin Nutr 2002; 21: 475-485
137. Ireton-Jones C, DeLegge M. Home parenteral nutrition registry: a five-year retrospective evaluation of outcomes of patients receiving home parenteral nutrition support. Nutrition 2005; 21: 156-160
138. Muscaritoli M, Grieco G, Capria S, Iori AP, Rossi FF. Nutritional and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr 2002; 75: 183-190
139. Herrmann VM, Petruska PJ. Nutrition support in bone marrow transplant recipients. Nutr Clin Pract 1993; 8: 19-27
140. Szeluga DJ, Stuart RK, Brookmeyer R, Utermohlen V, Santos GW. Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 1987; 47: 3309-3316
141. Raynard B, Nitenberg G, Gory-Delabaere G et al. Summary of the Standards, Options and Recommendations for nutritional support in patients undergoing bone marrow transplantation (2002). Br J Cancer 2003; 89, Suppl 1: S101-S106
142. Muscaritoli M, Conversano L, Torelli GF et al. Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation. Transplantation 1998; 66: 610-616
143. Cetin T, Arpaci F Dere Y et al. Total parenteral nutrition delays platelet engraftment in patients who undergo autologous hematopoietic stem cell transplantation. Nutrition 2002; 18: 599-603
144. Kajiume T, Yoshimi S, Kobayashi K, Kataoka N. Nutritional assessment of peripheral blood stem cell transplantation in children. Pediatr Hematol Oncol 2000; 17: 389-392
145. Pedron C, Madero L, Madero R, Garcia-Novo MD, Diaz MA, Hernandez M. Short-term follow-up of the nutritional status of children undergoing autologous peripheral blood stem cell transplantation. Pediatr Hematol Oncol 2000; 17: 559-566
146. Yokoyama S, Fujimoto T, Mitomi T, Yabe M, Yabe H, Kato S. Use of total parenteral nutrition in pediatric bone marrow transplantation. Nutrition 1989; 5: 27-30
147. Uderzo C, Rovelli A, Bonomi M, Fomia L, Pirovano L, Masera G. Total parenteral nutrition and nutritional assessment and leukaemic children undergoing bone marrow transplantation. Eur J Cancer 1991; 27: 758-762
148. Hopman GD, Pena EG, Cessie S Le, Weel MH Van, Vossen JM, Mearin ML. Tube feeding and bone marrow transplantation. Med Pediatr Oncol 2003; 40: 375-379
149. Langdana A, Tully N, Molloy E, Bourke B, O'Meara A. Intensive enteral nutrition support in paediatric bone marrow transplantation. Bone Marrow Transplant 2001; 27: 741-746
150. Ringwald-Smith KA, Hestop HE, Krance RA et al. Energy expenditure in children undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 30: 125-130
151. Duggan C, Bechard L, Donovan K et al. Changes in resting energy expenditure among children undergoing allogeneic stem cell transplantation. Am J Clin Nutr 2003; 78: 104-109
152. Forchielli ML, Azzi N, Cadranel S, Paolucci G. Total parenteral nutrition in bone marrow transplant: what is the appropriate energy level? Oncology 2003; 64: 7-13
153. MacFie J. Ethical implications of recognizing nutritional support as a medical therapy. Br J Surg 1996; 83: 1567-1568
154. Brozek J, Wells S, Keys A. Medical aspects of semistarvation in Leningrad (siege 1941 - 1942). Am Rev Sov Med 1946; 4: 70-86
155. Fliederbaum J. Clinical aspects of hunger disease in adults. In: Winnick M (ed): Hunger disease: Studies by the Jewish physicians in the Warsaw ghetto. New York: John Wiley 8; Sons, 1979: 11-43
156. Winnick M (Hrsg). Hunger disease: Studies by the jewish physicians in the Warsaw ghetto. New York: John Wiley & Sons, 1979
157. Bundesärztekammer. Grundsätze der Bundesärztekammer zur ärztlichen Sterbebegleitung. Deutsches Arzteblatt 1998; 95: B-1851-B-1853
158. Winkler MF. Quality of life in adult home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 2005; 29: 162-170
159. Bachmann P, Marti-Massoud C, Blanc-Vincent MP et al. Standards, options and recommendations: nutritional support in palliative or terminal care of adult patients with progressive cancer. Bull Cancer 2001; 88: 985-1006
160. McKinlay AW. Nutritional support in patients with advanced cancer: permission to fall out? Proc Nutr Soc 2004; 63: 431-435
161. McCann RM, Hall WJ, Groth-Juncker A. Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. JAMA 1994; 272: 1263-1266
162. Bruera E, Belzile M, Watanabe S, Fainsinger RL. Volume of hydration in terminal cancer patients. Support Care Cancer 1996; 4: 147-150
163. Burge F. Dehydration symptoms of palliative care cancer patients. J Pain Symptom Manage 1993; 8: 454-464
164. Ellershaw JE, Sutcliffe JM, Saunders CM. Dehydration and the dying patient. J Pain Symptom Manage 1995; 10: 192-197
165. Musgrave CF, Opstad J. Fluid retention and intravenous hydration in the dying. Palliat Med 1996; 10: 53
166. Fainsinger RL, Bruera E. When to treat dehydration in a terminally ill patient? Support Care Cancer 1997; 5: 205-211
167. Michaud L, Burnand B, Stiefel F. Taking care of the terminally ill cancer patient: delirium as a symptom of terminal disease. Ann Oncol 2005; 15, Suppl 4: iv199-iv203
168. Bruera E, Franco JJ, Maltoni M, Watanabe S, Suarez-Almazor M. Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation. J Pain Symptom Manage 1995; 10: 287-291
169. Stoutz ND de, Bruera E, Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 1995; 10: 378-384
170. Bruera E, Sola R, Rico MA et al. Effects of parenteral hydration in terminally ill cancer patients: a preliminary study. J Clin Oncol 2005; 23: 2366-2371
171. Bachmann P, Marti-Massoud C, Blanc-Vincent MP et al. Summary version of the Standards, Options and Recommendations for palliative or terminal nutrition in adults with progressive cancer (2001). Br J Cancer 2003; 89, Suppl 1: S107-S110